Stocks in news today

$LUPIN has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg. The USFDA has tentatively approved Lupin’s Enzalutamide Tablets, 40 mg and 80 mg as bioequivalent to reference listed drug (RLD) Xtandi Tablets of Astellas for the indication in the approved labeling. While Xtandi Tablets are traditionally available in 40 mg and 80 mg strengths, Lupin’s tentatively approved 120 mg and 160 mg strengths will provide healthcare providers and patients with alternative dosing options. $ASHOKA has received Letter of Acceptance (LoA) from Central Housing and Planning Authority, Guyana for Construction of Four Lane Highway from Versailles, West Bank Demerara to Parika, East Banbk Essequibo, Region No. 3 - Lots 1-17. The accepted value of the project is GYD$ 7,455,455,867 ($35.42 million). The said project is expected to be completed in 20 months. $TVSMOTOR has introduced exciting new colours and graphics for the TVS NTORQ 125 Disc and Race Edition variants. Building on the successful launch of the TVS NTORQ 150 and the feature upgrades introduced in the TVS NTORQ Race XP last year, this latest update revitalizes the TVS NTORQ portfolio ahead of the festive season. With its proven performance leadership in scooters, the new TVS NTORQ range now adds striking style enhancements that further elevate its sporty and youthful appeal.